Search clinical trials for: ONO-9054

Total 12396 results

Ono Pharma USA Inc

Completed

Single and Multiple Dose Escalation and Two-sequence Crossover Study of ONO-9054 in Patients With Ocular Hypertension or Mild Open-angle Glaucoma

Ocular Hypertension (OHT) | Mild Open Angle-glaucoma (OAG)

United States
Ono Pharma USA Inc

Completed

Single Dose Escalation Study of ONO-9054 in Healthy Volunteers

Healthy Adult Subjects

United States
Ono Pharmaceutical Co. Ltd

Completed

A 28 Day Study of ONO-9054 Ophthalmic Solution in Subjects With Ocular Hypertension (OHT) or Open-angle Glaucoma (OAG)

Ocular Hypertension | Open Angle-glaucoma

United States
GPCR Therapeutics, Inc.

Completed

Safety and PK/PD of TG-0054 in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients

Multiple Myeloma | Hodgkin Disease | Non-Hodgkin Lymphoma

Taiwan
GPCR Therapeutics, Inc.

Completed

Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of TG-0054 With Single IV Doses Escalation in Healthy Volunteers

Healthy

United States
Invicro

Completed

Assessment of [18F]MNI-1054 as a Marker for LSD1

Healthy Volunteers (HV)

United States
GPCR Therapeutics, Inc.

Completed

A Study to Evaluate the Safety, Pharmacokinetics, and Hematopoietic Stem Cell Mobilization of TG-0054 Alone or in Combination With G-CSF in Patients With Multiple Myeloma, Non-Hodgkin Lymphoma or Hodgkin Disease

Multiple Myeloma | Non-hodgkin's Lymphoma | Hodgkin's Disease

United States
Sarepta Therapeutics, Inc.
Nationwide Children's Hospital

Completed

A Gene Transfer Therapy Study to Evaluate the Safety of SRP-9004 (Patidistrogene Bexoparvovec) in Participants With Limb-Girdle Muscular Dystrophy, Type 2D (LGMD2D)

Limb-Girdle Muscular Dystrophy, Type 2D
Takeda
Takeda Development Center Americas, Inc.

Completed

A Study of TAK-954 to Treat Gastrointestinal Dysfunction in Adults After Surgery

Postoperative Gastrointestinal Dysfunction

United States, Germany
Millennium Pharmaceuticals, Inc.

Completed

A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of TAK-954 in Healthy Adult Participants

Healthy Volunteers

United States
Invicro

Completed

Assessment of the Biodistribution and Safety of [18F]MNI-1054

Healthy Volunteers

United States
Bispebjerg Hospital
University of Birmingham

Completed

Influence of Carbohydrate on Amino Acid Absorption From Dietary Protein (ICADP) (ICADP)

Muscle Protein Synthesis | Amino Acid

Denmark
Takeda

Completed

A Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics (PK) of a Single Intravenous (IV) TAK-954

Renal Impairment | Healthy Volunteers

Czechia, Hungary
Takeda

Completed

A Study to Evaluate the Effect of Hepatic Impairment on the Single Dose Pharmacokinetics (PK) of Intravenous TAK-954

Healthy Volunteers | Hepatic Impairment

Czechia, Slovakia
GPCR Therapeutics, Inc.

Completed

PD and Safety of TG-0054 Combined With G-CSF in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients

Multiple Myeloma | Hodgkin Disease | Non-Hodgkin Lymphoma

United States
AbbVie
Infinity Pharmaceuticals, Inc.

Completed

Study Evaluating Duvelisib in Japanese Subjects With Relapsed or Refractory Lymphoma

Lymphoma

Japan
Millennium Pharmaceuticals, Inc.

Completed

A Study to Evaluate the Mass Balance, Pharmacokinetics (PK), Metabolism and Excretion of TAK-954 Containing Microtracer ([14C]-TAK-954) in Healthy Male Participants

Healthy Volunteers

Netherlands
C. R. Bard

Completed

Lutonix® Global AV Registry Investigating Lutonix Drug Coated Balloon for Treatment of Native and Synthetic AV Fistulae (AVR)

Arteriovenous Fistula

United Kingdom, Singapore, France, Italy, Germany, Switzerland, Greece, Austria, Poland, Portugal, Saudi Arabia, Taiwan, Turkey
CytomX Therapeutics

Recruiting

A Trial to Find Safe and Active Doses for an Investigational Drug, CX-904, for Patients With Advanced Solid Tumors

Solid Tumors

United States
Takeda

Terminated

A Study With [18F]MNI-1054 to Determine Lysine -Specific Demethylase 1A (LSD1) Brain Enzyme Occupancy of TAK-418 After Single-Dose Oral Administration in Healthy Participants

Healthy Volunteers

United States
Catabasis Pharmaceuticals

Completed

A 2-Part, Phase 1, Single and Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of CAT-2054 in Healthy Subjects

Hypercholesterolemia

United States
College of Charleston

Completed

Investigation of the Role of 905-nm Laser Light in the Delay of Muscle Fatigue

Muscle Fatigue

United States
Takeda

Completed

Effect of TAK-954 on Gastrointestinal and Colonic Transit in Diabetic or Idiopathic Gastroparesis Participants

Diabetic Gastroparesis | Idiopathic Gastroparesis

United States
Pneumacare Ltd
Cambridge University Hospitals NHS Foundation Trust; University of Cambridge; Norfolk and Suffolk Primary and Community Care and other collaborators

Unknown

Thora-3Di™ Respiratory Rate Validation

Pulmonary Disease

United Kingdom
Case Comprehensive Cancer Center
National Institute on Minority Health and Health Disparities (NIMHD)

Completed

Attitudes, Beliefs, and Preferences of Older Stage I-III Breast Cancer Survivors Towards Physical Activity

Cancer Survivor | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer

United States
The Reading Hospital and Medical Center

Completed

Educational Intervention to Increase Physician Satisfaction and Effectiveness With a New Electronic Health Record

Attitude of Health Personnel

United States
Universidad de Zaragoza

Completed

Contextual Coaching Versus Training Workshop for Assistants in Special Education.

Caregiver | Disabled Persons
VA Office of Research and Development

Completed

Multimodal Treatment of Phonological Alexia: Behavioral & fMRI Outcomes

Stroke | Aphasia | Dyslexia, Acquired

United States
Centre de Recherche de l'Institut Universitaire...

Active, not recruiting

Group Versus Individual Physiotherapy for Urinary Incontinence in Aging Women (GROUP)

Urinary Incontinence | Urinary Stress Incontinence

Canada
University of Pittsburgh
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...

Completed

Promoting Lifestyle Change Via Tailored mHealth Feedback to Improve Health (SMARTER)

Overweight and Obesity

United States
Oregon Health and Science University
National Cancer Institute (NCI); National Institute of Arthritis and Musculoskeletal...

Completed

Promoting Healthy Lifestyles Among Firefighters (PHLAME)

Cardiovascular Diseases | Cancer | Physical Activity | Nutrition

United States
Harvard University

Completed

Couples Therapy for Alcoholic Patients (CALM)

Alcoholism

United States
Centers for Disease Control and Prevention
West Virginia University

Withdrawn

Colorectal Cancer Control in Appalachian Churches

Colorectal Cancer

United States
Biotronik SE & Co. KG

Completed

Fast VT Episodes Are Terminated by ATP One Shot (FavoriteATP)

Ventricular Tachycardia, Monomorphic

Austria, Finland, Germany, Israel
Case Comprehensive Cancer Center

Recruiting

Building Family Caregiver Skills Using a Simulation-Based Intervention for Care of Cancer Patients

Cancer

United States
Ege University

Enrolling by invitation

Exercise Training on Gait Pattern in Pregnancy

Pregnancy

Turkey
Ono Pharmaceutical Co. Ltd

Completed

A Study to Investigate the Effect of ONO-8539 on Acid-Induced Oesophageal Hypersensitivity in Healthy Volunteers

Acid Reflux

United Kingdom
Ono Pharmaceutical Co. Ltd

Completed

A Two-Part Study to Assess the Safety, Tolerability, PK and PD of ONO-7684 in Healthy Adult Volunteers

Venous Thromboembolism

United Kingdom
Ono Pharmaceutical Co. Ltd

Completed

Single-dose Study to Evaluate the Absolute Bioavailability and Mass Balance of ONO-5788 (ONO-5788-02)

Acromegaly

Netherlands
Mattias Lorentzon

Completed

The Effect of Mechanical Loading on Bone Material Strength and Microarchitecture in Postmenopausal Women

Osteoporosis | Postmenopause
University of California, Los Angeles

Active, not recruiting

Decreasing Physician Burnout With Professional Coaching

Burnout, Professional

United States
Ono Pharmaceutical Co. Ltd

Terminated

A Study to Evaluate ONO-4474 in Patients With Pain Due to Osteoarthritis of the Knee (MOTION)

Pain | Osteoarthritis, Knee

Poland, Hungary, Spain, Denmark, United Kingdom
Ono Pharma USA Inc

Completed

A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) (RESTORE)

Irritable Bowel Syndrome (IBS)

United States
Ono Pharma USA Inc

Completed

Multiple-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ONO-2952 in Healthy Adult Subjects

Healthy

United States
University of California, San Francisco
National Institute on Aging (NIA)

Recruiting

Advance Care Planning With Formerly Homeless Older Adults Residing in Permanent Supportive Housing (ACP-PSH)

Advance Care Planning

United States
Amgen

Withdrawn

Safety Evaluation of Panitumumab and Sirolimus in Advanced Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer | Oncology
Montefiore Medical Center
National Institute of Mental Health (NIMH); Albert Einstein College of Medicine and other collaborators

Terminated

Group Clinical Visit Adherence Intervention for HIV+ Women of Color

HIV/AIDS | Adherence, Patient | Group Meetings

United States
Northwestern University
Northeastern Illinois University

Recruiting

Patient Navigation 2.0

Cancer

United States
University of California, Los Angeles
National Institute of Mental Health (NIMH)

Completed

Randomized Study of Intensive One-on-one Behavioral Treatment for Preschool Aged Children With Autism

Autistic Disorder
The Queen Elizabeth Hospital
University of Adelaide

Completed

Improving Health for Aboriginal People Through Tobacco Related Research

Tobacco Dependence

Australia

Search clinical trials for: ONO-9054

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tunisia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations